Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.
Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience. Childs Nerv Syst. 2013 Apr; 29(4):589-96.
View in:
PubMed
subject areas
Adolescent
Adolescent
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Bevacizumab
Brain Neoplasms
Brain Neoplasms
Camptothecin
Camptothecin
Child
Child
Child, Preschool
Child, Preschool
Dacarbazine
Dacarbazine
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Humans
Humans
Infant
Infant
Male
Male
Medulloblastoma
Medulloblastoma
Recurrence
Recurrence
Retrospective Studies
Retrospective Studies
Treatment Outcome
Treatment Outcome
authors with profiles
Rene Yvonne McNall-Knapp